Work

Formulation and Evaluation of Mouth Dissolving Tablet of Metoclopramide: A Review

Year: 2024

Type: article

Abstract: Mouth-dissolving tablets (MDTs) are an innovative dosage form that offers convenience, rapid onset of action, and improved patient compliance, especially for pediatric, geriatric, and dysphagic patients. Metoclopramide, a dopamine receptor antagonist, is commonly used to treat nausea, vomiting, and various gastrointestinal disorders. Developing MDTs for Metoclopramide enhances therapeutic efficiency by ensuring faster disintegration, dissolution, and absorption. This review discusses formulation strategies, key excipients, preparation techniques, evaluation parameters, and future prospects for Metoclopramide MDTs, emphasizing their potential to improve patient compliance and clinical outcomes.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14357895

Author: Amol Dhayarkar*, Pravin Navgire, Dr. V. M. Satpute

Language: English

Topic: Drug Solubulity and Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6967932105

FWCI:

Cites:

Cited by:

Related to: